These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30305346)

  • 21. Manual Closed-Loop Insulin Delivery Using a Saddle Point Model Predictive Control Algorithm: Results of a Crossover Randomized Overnight Study.
    Guilhem I; Penet M; Paillard A; Carpentier M; Esvant A; Lefebvre MA; Poirier JY
    J Diabetes Sci Technol; 2017 Sep; 11(5):1007-1014. PubMed ID: 28677416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes.
    Elleri D; Allen JM; Biagioni M; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Acerini CL; Dunger DB; Hovorka R
    Pediatr Diabetes; 2012 Sep; 13(6):449-53. PubMed ID: 22817340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.
    Castle JR; El Youssef J; Wilson LM; Reddy R; Resalat N; Branigan D; Ramsey K; Leitschuh J; Rajhbeharrysingh U; Senf B; Sugerman SM; Gabo V; Jacobs PG
    Diabetes Care; 2018 Jul; 41(7):1471-1477. PubMed ID: 29752345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial.
    Dovc K; Piona C; Yeşiltepe Mutlu G; Bratina N; Jenko Bizjan B; Lepej D; Nimri R; Atlas E; Muller I; Kordonouri O; Biester T; Danne T; Phillip M; Battelino T
    Diabetes Care; 2020 Jan; 43(1):29-36. PubMed ID: 31575640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
    Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
    Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trial.
    Nimri R; Bratina N; Kordonouri O; Avbelj Stefanija M; Fath M; Biester T; Muller I; Atlas E; Miller S; Fogel A; Phillip M; Danne T; Battelino T
    Diabetes Obes Metab; 2017 Apr; 19(4):553-561. PubMed ID: 27981804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes.
    Maahs DM; Calhoun P; Buckingham BA; Chase HP; Hramiak I; Lum J; Cameron F; Bequette BW; Aye T; Paul T; Slover R; Wadwa RP; Wilson DM; Kollman C; Beck RW;
    Diabetes Care; 2014 Jul; 37(7):1885-91. PubMed ID: 24804697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control to range for diabetes: functionality and modular architecture.
    Kovatchev B; Patek S; Dassau E; Doyle FJ; Magni L; De Nicolao G; Cobelli C;
    J Diabetes Sci Technol; 2009 Sep; 3(5):1058-65. PubMed ID: 20144419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions.
    Grosman B; Ilany J; Roy A; Kurtz N; Wu D; Parikh N; Voskanyan G; Konvalina N; Mylonas C; Gottlieb R; Kaufman F; Cohen O
    J Diabetes Sci Technol; 2016 May; 10(3):708-13. PubMed ID: 26880389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extensive Assessment of Blood Glucose Monitoring During Postprandial Period and Its Impact on Closed-Loop Performance.
    Biagi L; Hirata Bertachi A; Conget I; Quirós C; Giménez M; Ampudia-Blasco FJ; Rossetti P; Bondia J; Vehí J
    J Diabetes Sci Technol; 2017 Nov; 11(6):1089-1095. PubMed ID: 28633537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of User-Initiated Intensification of Insulin Delivery Using Cambridge Hybrid Closed-Loop Algorithm.
    Ware J; Wilinska ME; Ruan Y; Allen JM; Boughton CK; Hartnell S; Bally L; de Beaufort C; Besser REJ; Campbell FM; Draxlbauer K; Elleri D; Evans ML; Fröhlich-Reiterer E; Ghatak A; Hofer SE; Kapellen TM; Leelarathna L; Mader JK; Mubita WM; Narendran P; Poettler T; Rami-Merhar B; Tauschmann M; Randell T; Thabit H; Thankamony A; Trevelyan N; Hovorka R
    J Diabetes Sci Technol; 2024 Jul; 18(4):882-888. PubMed ID: 36475908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study.
    Gingras V; Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
    Diabetes Technol Ther; 2016 Aug; 18(8):464-71. PubMed ID: 27191385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
    Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Model-based closed-loop glucose control in type 1 diabetes: the DiaCon experience.
    Schmidt S; Boiroux D; Duun-Henriksen AK; Frøssing L; Skyggebjerg O; Jørgensen JB; Poulsen NK; Madsen H; Madsbad S; Nørgaard K
    J Diabetes Sci Technol; 2013 Sep; 7(5):1255-64. PubMed ID: 24124952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes.
    Forlenza GP; Buckingham BA; Christiansen MP; Wadwa RP; Peyser TA; Lee JB; O'Connor J; Dassau E; Huyett LM; Layne JE; Ly TT
    Diabetes Technol Ther; 2019 May; 21(5):265-272. PubMed ID: 30925077
    [No Abstract]   [Full Text] [Related]  

  • 37. Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor.
    Finan DA; Dassau E; Breton MD; Patek SD; McCann TW; Kovatchev BP; Doyle FJ; Levy BL; Venugopalan R
    J Diabetes Sci Technol; 2015 Jun; 10(1):104-10. PubMed ID: 26134834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of overnight closed-loop control based on hourly blood glucose measurements.
    Patte C; Pleus S; Galley P; Weinert S; Haug C; Freckmann G
    J Diabetes Sci Technol; 2012 Jul; 6(4):902-9. PubMed ID: 22920817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hybrid closed-loop therapy: Where are we in 2021?
    Leelarathna L; Choudhary P; Wilmot EG; Lumb A; Street T; Kar P; Ng SM
    Diabetes Obes Metab; 2021 Mar; 23(3):655-660. PubMed ID: 33269551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring System.
    Peyser TA; Nakamura K; Price D; Bohnett LC; Hirsch IB; Balo A
    Diabetes Technol Ther; 2015 Aug; 17(8):548-54. PubMed ID: 25961446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.